Effectiveness of diabetes shared care program on metabolic indicators of people with type 2 diabetes: A systematic review and meta-analysis

Prim Care Diabetes. 2024 Jun;18(3):257-267. doi: 10.1016/j.pcd.2024.03.003. Epub 2024 Mar 15.

Abstract

Aims: To explore the effectiveness of the Taiwanese Diabetes Shared Care Program (DSCP) on improving the metabolic indicators of people with type 2 diabetes.

Methods: Relevant studies published between January 2002 and August 2021 were retrieved from Chinese- and English-language electronic databases, including PubMed, MEDLINE, CINAHL, ProQuest, Cochrane Library, Airiti Library, and Taiwan Periodical Literature System. After screening, studies that met inclusion criteria were included in the literature review. RevMan 5.4 was employed for a meta-analysis.

Results: Ten studies published between 2007 and 2021 were included in the systematic review, with nine of them contributing to the meta-analysis. In total, 1506 and 1388 participants were classified into DSCP and non-DSCP groups, respectively, for the meta-analysis. The results revealed that the DSCP significantly improved glycated hemoglobin levels (mean difference [MD]: -0.50, 95% Confidence Interval [CI]: -0.83 to -0.17) and body weights (MD: -0.83, 95% CI: -1.29 to -0.38) within 1-year follow-up. However, it did not show significant improvement in other metabolic indicators.

Conclusions: Taiwanese DSCP led to improvements in glycated hemoglobin levels and body weights among people with type 2 diabetes. This study suggests that people with diabetes and health-care institutions should consider participating in the DSCP.

Keywords: Diabetes Shared Care Program; Glycemic control; Health care; Metabolic indicators; Type 2 diabetes mellitus.

Publication types

  • Systematic Review
  • Meta-Analysis
  • Review

MeSH terms

  • Adult
  • Aged
  • Biomarkers* / blood
  • Blood Glucose / metabolism
  • Body Weight
  • Delivery of Health Care, Integrated*
  • Diabetes Mellitus, Type 2* / blood
  • Diabetes Mellitus, Type 2* / diagnosis
  • Diabetes Mellitus, Type 2* / epidemiology
  • Diabetes Mellitus, Type 2* / therapy
  • Female
  • Glycated Hemoglobin* / metabolism
  • Glycemic Control*
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Middle Aged
  • Program Evaluation
  • Taiwan / epidemiology
  • Time Factors
  • Treatment Outcome

Substances

  • Glycated Hemoglobin
  • Biomarkers
  • hemoglobin A1c protein, human
  • Blood Glucose
  • Hypoglycemic Agents